Cash cost of the wait: management is funding a defined waiting period whose end is already scheduled
The model's full reasoning — Q2 2022 call → NOWe need to determine if the transcript describes a defined waiting period the company is currently paying for out of its own pocket, with a specific near-dated end event, and that this is the main current work. Let's analyze the transcript. Key points: - Management discusses guidance, EBITDA, capacity additions. - They mention they are on track to deliver 8.2 GW operational by end of fiscal year (FY22). They have 7 GW operating now, with 400 MW scheduled in next couple of weeks. - They talk about projects under construction, supply cost inflation, but they expect equity IRR within target range. - They mention receivables, but that's not a waiting period. - They discuss corporate PPAs, M&A, etc. - They mention solar manufacturing: they are moving forward with a 2 GW module line, expecting output by end of next calendar year. They are waiting for government decision on production-linked incentive, but they are going ahead regardless. - They mention wind projects locked in at higher costs, but that's not a waiting period. The question is about a defined waiting period where the company is paying now for something not yet earning, and the end is a specific near-dated event. Look for any mention of a cost being borne now for a future benefit. For example, the 2 GW module line: they are building it, will start generating by end of next calendar year. That is a future benefit, but are they currently paying for it? Yes, they are investing in construction. But is that described as a "waiting period" that is the main current work? They mention it as part of their strategy, but not as a burden. They say they are going ahead with it. However, the question asks if management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. The module line is an investment, but is it causing a current cost that is impacting results? They don't explicitly say that the module line is causing a drag on earnings. They talk about EBITDA margins being high, and they are investing for growth. Another possibility: They mention that they have 1.2 GW with LoA but not yet PPA, and they are starting work on those projects. That could be a waiting period, but they are not necessarily paying for something that is not earning yet? They are starting work, but they haven't signed PPAs. However, they are doing generic work.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| LILA | Liberty Latin America Ltd. | Q4 2023 | 2024-02-23 | C |
| SBS | Companhia de Saneamento Básico do Estado | Q3 2023 | 2023-11-10 | C+ |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| DAN | Dana Incorporated | Q1 2017 | 2017-05-02 | B |
SBS · Q3 2023 → YESThe question is whether management describes the company as currently living through a defined waiting period it's paying for out of its own pocket. YES The transcript shows management describing the company as currently bearing real, ongoing cash costs (salaries, consulting, transition work) for the IDP/restructuring program whose benefits (full expense reduction, shared-services center operational) are not yet realized. The far side is a specific, near-dated event: full 3.7% staff reduction and shared-services center operational by mid-2024 (July 2024 for full benefit), with the program already in motion and on schedule. Management frames this as the main current work, not a setback, and treats the costs as self-funded. This meets all three conditions.
EHTH · Q2 2021 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing the company as currently living through a defined waiting period for the AEP, paying for it out of its own pocket through heavy investments in internal agents and quality initiatives. They hired agents early, many still in training with lower productivity, and are bearing the cost of additional training and customer service expansion in Q3. This is framed as a chosen investment to improve enrollment quality and prepare for the fourth-quarter AEP, not an apology or external issue.
YUM · Q2 2018 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing a clear, self-funded transition cost tied to the refranchising effort. They explicitly call out the “timing mismatch between G&A savings and refranchising” as one of the four items weighing on Q2 core operating profit, and they quantify the full-year headwind at 6 7 percentage points. This is presented as a real, ongoing drag on current results while they complete the shift to 98 % franchised by year-end 2018 and reach the 1.7 % G&A run-rate target in 2019.